COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,588 Articles (22,415 medRxiv, 8,173 bioRxiv)

Most recent first Previous |  Page 1720: Articles 17191-17200  | Next

Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
Ziegler, C. G. K., Miao, V. N., Owings, A. H., Navia, A. W., Tang, Y., Bromley, J. D., Lotfy, P., Sloan, M., Laird, H., Williams, H. B., George, M., Drake, R. S., Christian, T., Parker, A., Sindel, C. B., Burger, M. W., Pride, Y., Hasan, M., Abraham, G. E., Senitko, M., Robinson, T. O., Shalek, A. K., Glover, S. C., Horwitz, B. H., Ordovas-Montanes, J.
10.1101/2021.02.20.431155 — Posted: 2021-02-20 Discussion: Offsite
Evaluation of rapid antibody test and chest computed tomography results of COVID-19 patients: A retrospective study
Ozturk, A., Bozok, T., Simsek Bozok, T.
10.1101/2021.02.15.21251772 — Posted: 2021-02-20
Predicting mortality, duration of treatment, pulmonary embolism and required ceiling of ventilatory support for COVID-19 inpatients: A Machine-Learning Approach
Vepa, A., Saleem, A., Rakhshanbabanari, K., Omar, A., Dharmaraj, D., Sami, J., Parekh, S., Ibrahim, M., Raza, M., Kapila, P., Chakrabarti, P., Sedighi, T., Chatrabgoun, O., Daneshkhah, A.
10.1101/2021.02.15.21251752 — Posted: 2021-02-20
Modafinil for Wakefulness in the Critical Care Units: A Case Series including COVID-19 Patients at a Tertiary Care Saudi Hospital
Amer, M. R., Bawazeer, M., Butt, A. S., Dahhan, T. I., Kseibi, E., Jamil, M. G.
10.1101/2021.02.11.21250832 — Posted: 2021-02-19
Clustering of Countries for COVID-19 Cases based on Disease Prevalence, Health Systems and Environmental Indicators
Rizvi, A., Umair, M., Cheema, M. A.
10.1101/2021.02.15.21251762 — Posted: 2021-02-19
The Effect of NFL and NCAA Football Games on the Spread of COVID-19 in the United States: An Empirical Analysis
Toumi, A., Zhao, H., Chhatwal, J., Linas, B. P., Ayer, T.
10.1101/2021.02.15.21251745 — Posted: 2021-02-19
Repurposing Colchicine for the management of COVID-19: A systematic review and meta-analysis
Mohanty, R. R., Meher, B. R., Padhy, B. M., Das, S.
10.1101/2021.02.17.21251884 — Posted: 2021-02-19
Adequate knowledge of COVID-19 impacts good practices amongst health profession students in the Philippines
Dalanon, J., Redoble, R., Belotindos, J.-A., Delos Reyes, C., Fabillar, J., Armero, M. S., Locsin, R., Suzuki, Y., Okura, K., Matsuka, Y.
10.1101/2021.02.18.431919 — Posted: 2021-02-19
Probing the SAM Binding Site of SARS-CoV-2 nsp14 in vitro Using SAM Competitive Inhibitors Guides Developing Selective bi-substrate Inhibitors
Devkota, K., Schapira, M., Perveen, S., Khalili Yazdi, A., Li, F., Chau, I., Ghiabi, P., Hajian, T., Loppnau, P., Bolotokova, A., Satchell, K. J., Wang, K., Li, D., Liu, J., Smil, D., Luo, M., Jin, J., Fish, P. V., Brown, P. J., Vedadi, M.
10.1101/2021.02.19.424337 — Posted: 2021-02-19
Delivery of recombinant SARS-CoV-2 envelope protein into human cells
Hutchison, J. M., Capone, R., Luu, D. D., Hadziselimovic, A., Van Horn, W. D., Sanders, C. R.
10.1101/2021.02.18.431684 — Posted: 2021-02-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).